All In Biotech

Free tool

FAERS Monitor: Isovue-370

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020327 or its brand name (Isovue-370, Iopamidol). Reports on generic versions are filed under their own applications.

Reports

2,951

Serious

2,159

73% of reports

Hospitalization

1,055

Death reported

261

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea191
  • urticaria191
  • anaphylactic reaction186
  • pruritus174
  • nausea164
  • contrast media reaction144
  • no adverse event140
  • vomiting122
  • acute kidney injury115
  • hypersensitivity110
  • off label use93
  • dizziness89
  • erythema86
  • cough81
  • anaphylactic shock78

Reports by year received

View as table
YearReports
200432
200536
20067
200720
200825
200923
201059
201182
201278
2013129
2014146
2015149
2016160
2017203
2018207
2019282
2020172
2021193
2022186
2023140
2024169
2025185
2026268

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,208 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
contrast media reactionSignal144463.1392.861,929
anaphylactic reactionSignal18624.120.94,087
anaphylactic shockSignal7821.617.41,512
urticariaSignal1918.17.11,196
no adverse eventSignal1405.54.7516
acute kidney injurySignal1155.44.5406
hypersensitivitySignal1104.23.5270
pruritusSignal1743.22.8270
erythemaSignal863.02.4112
dyspnoeaSignal1912.42.1160
coughSignal812.11.744
vomiting1221.81.648
nausea1641.51.326
dizziness891.31.05
off label use930.80.67

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.